Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
AI Diagnoses Corneal Infections as Accurately as Doctors
Artificial intelligence (AI) is emerging as a valuable tool in diagnosing infectious keratitis (IK), a leading cause of corneal blindness worldwide. A recent study published in eClinicalMedicine has shown that deep learning (DL) models demonstrate similar diagnostic accuracy to ophthalmologists…
Cataract Surgery Lowers Risk of Falls and Injuries
Cataract surgery is well-known for restoring vision, but a new study reveals it may also play a vital role in reducing life-threatening injuries. Research presented at the annual meeting of the American Academy of Ophthalmology in Chicago suggests that older…
New Imaging Boosts Geographic Atrophy Diagnosis
At the 2024 American Academy of Ophthalmology (AAO) meeting in Chicago, Dr. SriniVas R. Sadda discussed the evolving landscape of imaging technologies for diagnosing geographic atrophy (GA). While traditional methods like flash color fundus photography have been the gold standard…
ANX007 Protects Vision in Dry AMD – AAO 2024
A new investigational drug, ANX007, offers hope for the millions of people suffering from geographic atrophy, a severe form of dry age-related macular degeneration (AMD). The drug’s potential to reduce vision loss and protect essential retinal structures was highlighted at…
Long-Term Antiviral Therapy for Ocular Shingles
A new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania and the NYU Grossman School of Medicine suggests that taking an antiviral medication for a year can help prevent vision loss caused by…
Google AI for Diabetic Retinopathy in India, Thailand
Google recently announced the licensing of its diabetic retinopathy AI model to healthcare providers and health-tech partners in India and Thailand, aiming to provide millions of free screenings to underserved communities. Expanding Access to Eye Care Over the next decade,…
SLT Beats Medications in Glaucoma – AAO 2024
A recent retrospective analysis of the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial data demonstrated that selective laser trabeculoplasty (SLT) as a first-line treatment significantly outperforms glaucoma medications in reducing the rate of visual field (VF) loss. This study,…
OSA 2024 Winners Highlight Innovations in Ophthalmology
VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, handed the prestigious Ophthalmology Star Awards 2024 (OSA) to its owners during the Satellite Symposium at the ESCRS 2024 Congress in Barcelona. The awards, which were personally presented to…
New Drug Targets for Inherited Retinal Diseases Identified
An international team of researchers has discovered new drug targets for inherited retinal diseases, such as retinitis pigmentosa (RP). Using advanced proteomics, they identified common critical pathways in different disease models, offering hope for broad-spectrum treatments. Key Findings in Retinitis…
Ophthalmic Drug Delivery Summit 2024
In January, over 60 world-renowned experts in ophthalmic drug delivery will gather in San Francisco for the 3rd annual Ophthalmic Drug Delivery Summit. This industry-focused event aims to advance effectiveness, durability, and minimally invasive techniques in retinal drug delivery. Key…